Surge in Adoption of the Steritas eCOA Suite Continues
Ever since the introduction of the Steritas Glucocorticoid Toxicity Index (GTI) in 2017, there has been a remarkable surge in the number of clinicians and clinical researchers using Steritas's ...
Study Highlights Significant Unmet Needs of Polymyalgia Rheumatica Patients
Results from a Phase 3 clinical trial reported in The New England Journal of Medicine,[1] have highlighted the significant unmet need for effective long-term treatments for those battling polymyalgia ...
In Conversation With… Jane McDowell, MBBS BSc PhD
“Steroid use is prevalent among severe asthma patients, in part due to physician training that emphasizes the effectiveness of steroids rather than their potential dangers.” Jane McDowell, MBBS BSc ...
Risk Factors for Steroid-toxicity and Cardiovascular Disease Overlap
A new study published in the New England Journal of Medicine shows the incidence of cardiovascular disease correlates strongly with the four metabolic domains used in the Steritas GTI-MD (body mass ...
Discovering Steroid-toxicity Secrets Concealed in Large Datasets
A challenge that has vexed health systems and payers for decades is the inability to fully quantify the long-term impacts of steroid-toxicity. Set to change that paradigm is the GTI-MD, an ...
Curious about the true cost of steroid-toxicity?
Download our infographic today
